LIGHT SCIENCES ONCOLOGY INC

Overview

LIGHT SCIENCES ONCOLOGY INC is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering TALAPORFIN SODIUM (LS11) LYOPHILIZED DRUG PRODUCT FORMULATION AND FILLING.

Therapeutic areas

API / Drug Master Files

LIGHT SCIENCES ONCOLOGY INC holds 1 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TALAPORFIN SODIUM (LS11) LYOPHILIZED DRUG PRODUCT FORMULATION AND FILLINGActive2009-01-15
• TALAPORFIN SODIUM (LS11) LYOPHILIZED DRUG PRODUCTInactive2005-09-15

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LIGHT SCIENCES ONCOLOGY INC in our records. PharmaTek screens the full directory against live FDA enforcement data.